Target Price | $52.61 |
Price | $42.48 |
Potential | 23.84% |
Number of Estimates | 23 |
23 Analysts have issued a price target Baker Hughes 2026 . The average Baker Hughes target price is $52.61. This is 23.84% higher than the current stock price. The highest price target is $58.00 36.53% , the lowest is $40.00 5.84% . | |
A rating was issued by 29 analysts: 22 Analysts recommend Baker Hughes to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2026 of 23.84% . Most analysts recommend the Baker Hughes stock at Purchase. |
22 Analysts have issued a sales forecast Baker Hughes 2025 . The average Baker Hughes sales estimate is $27.9b . This is 0.16% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $28.3b 1.84% , the lowest is $27.7b 0.43% .
This results in the following potential growth metrics:
2024 | $27.8b | 9.11% |
---|---|---|
2025 | $27.9b | 0.16% |
2026 | $29.0b | 4.03% |
2027 | $29.9b | 3.17% |
2028 | $30.5b | 1.82% |
2029 | $30.0b | 1.48% |
23 Analysts have issued an Baker Hughes EBITDA forecast 2025. The average Baker Hughes EBITDA estimate is $5.0b . This is 9.76% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.1b 12.40% , the lowest is $4.6b 2.88% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.5b | 21.22% |
---|---|---|
2025 | $5.0b | 9.76% |
2026 | $5.4b | 9.79% |
2027 | $5.8b | 6.71% |
2028 | $6.1b | 4.36% |
2029 | $5.9b | 2.14% |
2024 | 16.23% | 11.10% |
---|---|---|
2025 | 17.79% | 9.58% |
2026 | 18.78% | 5.56% |
2027 | 19.42% | 3.41% |
2028 | 19.91% | 2.52% |
2029 | 19.77% | 0.70% |
11 Baker Hughes Analysts have issued a net profit forecast 2025. The average Baker Hughes net profit estimate is $2.6b . This is 13.00% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.7b 9.50% , the lowest is $2.5b 15.44% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.9b | 56.02% |
---|---|---|
2025 | $2.6b | 13.00% |
2026 | $2.9b | 14.09% |
2027 | $3.3b | 12.37% |
2024 | 10.60% | 43.00% |
---|---|---|
2025 | 9.20% | 13.19% |
2026 | 10.09% | 9.67% |
2027 | 10.99% | 8.92% |
11 Analysts have issued a Baker Hughes forecast for earnings per share. The average Baker Hughes <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $2.59 . This is 13.09% lower than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.70 9.40% , the lowest is $2.52 15.44% .
This results in the following potential growth metrics and future valuations:
2024 | $2.98 | 56.02% |
---|---|---|
2025 | $2.59 | 13.09% |
2026 | $2.96 | 14.29% |
2027 | $3.32 | 12.16% |
Current | 14.26 | 10.82% |
---|---|---|
2025 | 16.39 | 14.94% |
2026 | 14.36 | 12.39% |
2027 | 12.78 | 11.00% |
Based on analysts' sales estimates for 2025, the Baker Hughes stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.59 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 1.51 .
This results in the following potential growth metrics and future valuations:
Current | 1.59 | 19.55% |
---|---|---|
2025 | 1.59 | 0.11% |
2026 | 1.53 | 3.88% |
2027 | 1.48 | 3.07% |
2028 | 1.45 | 1.78% |
2029 | 1.48 | 1.50% |
Current | 1.51 | 25.88% |
---|---|---|
2025 | 1.51 | 0.17% |
2026 | 1.45 | 3.88% |
2027 | 1.41 | 3.07% |
2028 | 1.38 | 1.79% |
2029 | 1.40 | 1.50% |
Analyst | Rating | Action | Date |
---|---|---|---|
Benchmark |
Buy
➜
Buy
|
Unchanged | Feb 11 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 04 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Feb 03 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Feb 03 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Feb 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Benchmark:
Buy
➜
Buy
|
Feb 11 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 04 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Feb 03 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Feb 03 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Feb 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.